Literature DB >> 16096523

Headache symptoms in pediatric sickle cell patients.

Tonya M Palermo1, Candis Platt-Houston, Raechel E Kiska, Brian Berman.   

Abstract

The purposes of this study were to determine the characteristics of headaches in children with sickle cell disease (SCD) and to assess the relationship between headache symptoms and children's physical and emotional status. A detailed headache questionnaire using International Classification of Headache Disorders (ICHD-2) criteria was mailed to a cohort (n = 50) of children with SCD, ages 9 to 17 years. Respondents also completed measures of functional disability and psychological distress. Headaches had occurred over the previous 3-month period in 76.2% of the patients. Frequent headaches were common, occurring greater than once a week in 31.2% of children. Average pain severity was reported as moderate on a 0-to-10 scale (mean = 5.8). Duration of headaches ranged from 30 minutes to several days, with a mean of 5 hours. Based on ICHD-2 criteria, 43.8% of children had headache symptoms consistent with migraines, 6.2% with migraine with aura, and 50.0% with tension-type headaches. Children with symptoms of migraine had significantly greater functional disability compared with children with symptoms of tension-type headaches (P < 0.01). Further studies to determine the characteristics and determinants of headaches experienced in SCD patients will help maximize treatment of headaches and enhance daily functioning in these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16096523      PMCID: PMC1351111          DOI: 10.1097/01.mph.0000175408.27180.8e

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  20 in total

Review 1.  Management of sickle cell disease.

Authors:  M H Steinberg
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

2.  Epidemiology of migraine among students from randomly selected secondary schools in Lodz.

Authors:  W Split; W Neuman
Journal:  Headache       Date:  1999 Jul-Aug       Impact factor: 5.887

3.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

4.  Chronic pain and its impact on quality of life in adolescents and their families.

Authors:  J A Hunfeld; C W Perquin; H J Duivenvoorden; A A Hazebroek-Kampschreur; J Passchier; L W van Suijlekom-Smit; J C van der Wouden
Journal:  J Pediatr Psychol       Date:  2001 Apr-May

5.  Depression and functional disability in chronic pediatric pain.

Authors:  S Kashikar-Zuck; K R Goldschneider; S W Powers; M H Vaught; A D Hershey
Journal:  Clin J Pain       Date:  2001-12       Impact factor: 3.442

6.  Pain among children and adolescents: restrictions in daily living and triggering factors.

Authors:  Angela Roth-Isigkeit; Ute Thyen; Hartmut Stöven; Johanna Schwarzenberger; Peter Schmucker
Journal:  Pediatrics       Date:  2005-02       Impact factor: 7.124

7.  Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample.

Authors:  Bruce F Chorpita; Catherine E Moffitt; Jennifer Gray
Journal:  Behav Res Ther       Date:  2005-03

8.  A randomized trial of electronic versus paper pain diaries in children: impact on compliance, accuracy, and acceptability.

Authors:  Tonya M Palermo; Duaré Valenzuela; Paul P Stork
Journal:  Pain       Date:  2004-02       Impact factor: 6.961

9.  Parental report of health-related quality of life in children with sickle cell disease.

Authors:  Tonya Mizell Palermo; Lisa Schwartz; Dennis Drotar; Kathryn McGowan
Journal:  J Behav Med       Date:  2002-06

10.  Determinants of tension-type headache in children.

Authors:  P Anttila; L Metsähonkala; M Aromaa; A Sourander; J Salminen; H Helenius; P Alanen; M Sillanpää
Journal:  Cephalalgia       Date:  2002-06       Impact factor: 6.292

View more
  9 in total

1.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 2.  Headache and Facial Pain in Sickle Cell Disease.

Authors:  Angeliki Vgontzas; Larry Charleston; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2016-03

3.  Systematic Review: Pain and Emotional Functioning in Pediatric Sickle Cell Disease.

Authors:  Steven K Reader; Laura M Rockman; Katherine M Okonak; Nicole M Ruppe; Colleen N Keeler; Anne E Kazak
Journal:  J Clin Psychol Med Settings       Date:  2020-06

Review 4.  Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability.

Authors:  Fenella J Kirkham; Avijit K Datta
Journal:  Dev Sci       Date:  2006-07

5.  Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Authors:  Michael M Dowling; Michael J Noetzel; Mark J Rodeghier; Charles T Quinn; Deborah G Hirtz; Rebecca N Ichord; Janet L Kwiatkowski; E Steven Roach; Fenella J Kirkham; James F Casella; Michael R DeBaun
Journal:  J Pediatr       Date:  2014-02-13       Impact factor: 4.406

Review 6.  Medical causes of headache in children.

Authors:  Nicholas S Abend; Donald Younkin
Journal:  Curr Pain Headache Rep       Date:  2007-10

7.  Headache in children with sickle cell disease: prevalence and associated factors.

Authors:  Alison E Niebanck; Avrum N Pollock; Kim Smith-Whitley; Leslie J Raffini; Robert A Zimmerman; Kwaku Ohene-Frempong; Janet L Kwiatkowski
Journal:  J Pediatr       Date:  2007-07       Impact factor: 4.406

8.  Aura and mental stress are associated with reports of pain in sickle cell disease-a pilot study using a mobile application.

Authors:  Juan Espinoza; Payal Shah; Saranya Veluswamy; Lonnie Zeltzer; Michael C K Khoo; Thomas D Coates; Jacquelyn Baskin
Journal:  Am J Hematol       Date:  2020-02-05       Impact factor: 10.047

9.  Reversible posterior leukoencephalopathy syndrome in sickle-cell anemia.

Authors:  Richard E Frye
Journal:  Pediatr Neurol       Date:  2009-04       Impact factor: 3.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.